Literature DB >> 7526947

Localisation of hyaluronate (HA) in primary tumors and nude mouse xenografts of human pancreatic carcinomas using a biotinylated HA-binding protein.

H Fries1, H P Elsässer, V Mahlbacher, K Neumann, H F Kern.   

Abstract

A biotinylated hyaluronate (HA)-binding protein isolated from bovine cartilage was used to analyze the distribution of HA in nude mouse xenografts derived from human pancreatic adenocarcinoma cell lines as well as in primary human pancreatic adenocarcinomas. The most reproducible results for the localisation of HA were obtained using cryostat sections. When the biotinylated HA-binding protein was applied to histological sections of nude mouse xenografts, the specific staining found could be inhibited by preincubating the HA-binding protein with an excess of HA or by hyaluronidase treatment of the tissue before staining. The highest HA concentration was found at the tumor boundaries, while in the central part of the tumor staining was slight or absent. In cryostat sections of primary tumors HA was found predominantly in the connective tissue immediately around tumor cells or at the border between the tumor and normal pancreatic tissue.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7526947     DOI: 10.1007/bf00197386

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  25 in total

1.  Identification and regulation of the eukaryotic hyaluronate synthase.

Authors:  P Prehm
Journal:  Ciba Found Symp       Date:  1989

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  The isolation and characterization of the link proteins from proteoglycan aggregates of bovine nasal cartilage.

Authors:  J R Baker; B Caterson
Journal:  J Biol Chem       Date:  1979-04-10       Impact factor: 5.157

5.  Variation in glycosaminoglycan components of breast tumors.

Authors:  J Takeuchi; M Sobue; E Sato; M Shamoto; K Miura
Journal:  Cancer Res       Date:  1976-07       Impact factor: 12.701

6.  Structural analysis of a new highly metastatic cell line PaTu 8902 from a primary human pancreatic adenocarcinoma.

Authors:  H P Elsässer; U Lehr; B Agricola; H F Kern
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1993

7.  Interactions between human tumor cells and fibroblasts stimulate hyaluronate synthesis.

Authors:  W Knudson; C Biswas; B P Toole
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

8.  Glycosaminoglycans in human lung cancer.

Authors:  T Horai; N Nakamura; R Tateishi; S Hattori
Journal:  Cancer       Date:  1981-11-01       Impact factor: 6.860

Review 9.  The role and regulation of tumour-associated hyaluronan.

Authors:  W Knudson; C Biswas; X Q Li; R E Nemec; B P Toole
Journal:  Ciba Found Symp       Date:  1989

10.  The hyaluronate receptor is preferentially expressed on proliferating epithelial cells.

Authors:  A M Alho; C B Underhill
Journal:  J Cell Biol       Date:  1989-04       Impact factor: 10.539

View more
  11 in total

1.  Expression of the hyaluronan receptor RHAMM in endometrial carcinomas suggests a role in tumour progression and metastasis.

Authors:  D T Rein; K Roehrig; T Schöndorf; A Lazar; M Fleisch; D Niederacher; H G Bender; P Dall
Journal:  J Cancer Res Clin Oncol       Date:  2003-02-20       Impact factor: 4.553

2.  A novel epigenetic mechanism regulating hyaluronan production in pancreatic cancer cells.

Authors:  Shiro Kohi; Norihiro Sato; Xiao-Bo Cheng; Atsuhiro Koga; Aiichiro Higure; Keiji Hirata
Journal:  Clin Exp Metastasis       Date:  2015-11-20       Impact factor: 5.150

3.  Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer.

Authors:  Michael A Jacobetz; Derek S Chan; Albrecht Neesse; Tashinga E Bapiro; Natalie Cook; Kristopher K Frese; Christine Feig; Tomoaki Nakagawa; Meredith E Caldwell; Heather I Zecchini; Martijn P Lolkema; Ping Jiang; Anne Kultti; Curtis B Thompson; Daniel C Maneval; Duncan I Jodrell; Gregory I Frost; H M Shepard; Jeremy N Skepper; David A Tuveson
Journal:  Gut       Date:  2012-03-30       Impact factor: 23.059

4.  Hyaluronan and hyaluronan binding proteins are normal components of mouse pancreatic islets and are differentially expressed by islet endocrine cell types.

Authors:  Rebecca L Hull; Pamela Y Johnson; Kathleen R Braun; Anthony J Day; Thomas N Wight
Journal:  J Histochem Cytochem       Date:  2012-07-21       Impact factor: 2.479

5.  Hyaluronan stimulates pancreatic cancer cell motility.

Authors:  Xiao-Bo Cheng; Shiro Kohi; Atsuhiro Koga; Keiji Hirata; Norihiro Sato
Journal:  Oncotarget       Date:  2016-01-26

Review 6.  Role of hyaluronan in pancreatic cancer biology and therapy: Once again in the spotlight.

Authors:  Norihiro Sato; Shiro Kohi; Keiji Hirata; Michael Goggins
Journal:  Cancer Sci       Date:  2016-03-18       Impact factor: 6.716

7.  4-Methylumbelliferone Suppresses Hyaluronan Synthesis and Tumor Progression in SCID Mice Intra-abdominally Inoculated With Pancreatic Cancer Cells.

Authors:  Hayato Nagase; Daisuke Kudo; Akiko Suto; Eri Yoshida; Shinichiro Suto; Mika Negishi; Ikuko Kakizaki; Kenichi Hakamada
Journal:  Pancreas       Date:  2017-02       Impact factor: 3.327

8.  Prognostic impact of hyaluronan and its regulators in pancreatic ductal adenocarcinoma.

Authors:  Xiao-Bo Cheng; Norihiro Sato; Shiro Kohi; Koji Yamaguchi
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

Review 9.  Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma.

Authors:  Norihiro Sato; Xiao-Bo Cheng; Shiro Kohi; Atsuhiro Koga; Keiji Hirata
Journal:  Acta Pharm Sin B       Date:  2016-01-21       Impact factor: 11.413

10.  4-Methylumbelliferone inhibits enhanced hyaluronan synthesis and cell migration in pancreatic cancer cells in response to tumor-stromal interactions.

Authors:  Xiao-Bo Cheng; Norihiro Sato; Shiro Kohi; Atsuhiro Koga; Keiji Hirata
Journal:  Oncol Lett       Date:  2018-03-01       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.